Key Segmentation
By Test Type
-
Urinalysis
-
Urine Culture
-
Susceptibility Testing
By Test Kit Type
-
Laboratory Test Kits
-
Home Test Kits
By Infection Type
-
Cystitis
-
Urethritis
-
Pyelonephritis
By End User
-
Hospitals
-
Diagnostic Laboratories
-
Homecare Settings
-
Others
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market player
Frequently Asked Questions
Key players include Abbott Laboratories, ACON Laboratories, Inc., Bio-Rad Laboratories, Inc., Cardinal Health, Inc., F. Hoffmann-La Roche Ltd, Laboratory Corporation of America Holdings (Labcorp), Quest Diagnostics Incorporated and Thermo Fisher Scientific Inc.
Key opportunities include rapid point-of-care susceptibility testing, home testing linked to telehealth, and low-cost tests for emerging markets.
The major growth factor is rising antibiotic resistance, which increases the need to confirm the cause of infection and choose an effective drug.
By Test Type, the Urinalysis segment dominated the market in 2025 with an estimated 46.00% share, supported by its low cost, speed and use as the first test.
North America dominated the market with a share of 36.00% in 2025, driven by high testing volumes, large laboratory networks and broad insurance coverage.
